Patent Yard Sign in
Canadian application, no grantCanada

Methods and apparatus for sclerosing the wall of a varicose vein

CA 2452369 A1 · Owner: Syntheon, Llc · Inventors: Gottlieb, Saul; Slater, Charles R.; Lary, Banning G.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A preferred apparatus for delivering an intravascular drug such as a sclerosing agent (or a microfoam sclerosing agent) to a varicose vein includes a catheter (10) having three concentric tubes (12 14, 16). The innermost tube , (12) has a guide wire lumen (18) and an inflation lumen (20). The distal end of the innermost tube (12) has integral inflatable occlusion balloon (24) in fluid communication with the inflation lumen (20). The intermediate tube (16) has a lumen through which the innermost tube extends. The distal end of the intermediate tube (16) has a self-expanding balloon (28) with a plurality of fluid pores in fluid communication with the intermediate tube lumen. The outer …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 3, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 3, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 3, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 3, 2002
GrantedNo grant recorded
Term endedJuly 3, 2022
Patent numberCA 2452369 A1
Classification (IPC)A61M29/00 +1 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJuly 3, 2002Term endedJuly 3, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.